Sirona Biochem Corp (SBM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sirona Biochem Corp (SBM) has a cash flow conversion efficiency ratio of 0.160x as of July 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-552.59K ≈ $-399.74K USD) by net assets (CA$-3.46 Million ≈ $-2.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sirona Biochem Corp market cap and net worth for the company's overall valuation and market capitalisation.
Sirona Biochem Corp - Cash Flow Conversion Efficiency Trend (2011–2023)
This chart illustrates how Sirona Biochem Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sirona Biochem Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sirona Biochem Corp ranked by their cash flow conversion efficiency. Explore Sirona Biochem Corp cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RomReal Limited
OL:ROM
|
-0.020x |
|
Dycasa SA
BA:DYCA
|
-0.135x |
|
Mitra Angkasa Sejahtera PT Tbk
JK:BAUT
|
0.008x |
|
Primeserv Group Ltd
JSE:PMV
|
0.214x |
|
Northeast Electric Development Company Limited
F:NE4H
|
0.009x |
|
InnSuites Hospitality Trust
NYSE MKT:IHT
|
0.988x |
|
Ekiz Kimya Sanayi ve Ticaret AS
IS:EKIZ
|
-0.296x |
|
Inepar S.A. Indústria e Construções
SA:INEP3
|
0.014x |
Annual Cash Flow Conversion Efficiency for Sirona Biochem Corp (2011–2023)
The table below shows the annual cash flow conversion efficiency of Sirona Biochem Corp from 2011 to 2023. View Sirona Biochem Corp (SBM) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-10-31 | CA$-2.51 Million ≈ $-1.82 Million |
CA$-1.76 Million ≈ $-1.27 Million |
0.700x | +106.89% |
| 2022-10-31 | CA$214.51K ≈ $155.18K |
CA$-2.18 Million ≈ $-1.58 Million |
-10.151x | -145.63% |
| 2021-10-31 | CA$-97.02K ≈ $-70.18K |
CA$-2.16 Million ≈ $-1.56 Million |
22.246x | +149.92% |
| 2020-10-31 | CA$47.40K ≈ $34.28K |
CA$-2.11 Million ≈ $-1.53 Million |
-44.564x | -2641.24% |
| 2019-10-31 | CA$2.19 Million ≈ $1.58 Million |
CA$-3.56 Million ≈ $-2.57 Million |
-1.626x | -719.47% |
| 2018-10-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-593.35K ≈ $-429.22K |
0.262x | -78.57% |
| 2017-10-31 | CA$-2.04 Million ≈ $-1.48 Million |
CA$-2.50 Million ≈ $-1.81 Million |
1.225x | +191.01% |
| 2016-10-31 | CA$1.56 Million ≈ $1.13 Million |
CA$-2.10 Million ≈ $-1.52 Million |
-1.346x | +5.71% |
| 2015-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-3.06 Million ≈ $-2.22 Million |
-1.427x | -37.36% |
| 2014-10-31 | CA$1.79 Million ≈ $1.30 Million |
CA$-1.86 Million ≈ $-1.35 Million |
-1.039x | +10.78% |
| 2013-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-2.50 Million ≈ $-1.81 Million |
-1.164x | +7.70% |
| 2012-10-31 | CA$1.70 Million ≈ $1.23 Million |
CA$-2.15 Million ≈ $-1.55 Million |
-1.261x | -35.27% |
| 2011-10-31 | CA$2.72 Million ≈ $1.97 Million |
CA$-2.54 Million ≈ $-1.84 Million |
-0.933x | -- |
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more